Coremend (TB4, KPV, BPC157) 25mg+10mg+10mg (Haɗa)

▎ Menene KPV?

KPV wani fili ne na tripeptide wanda ya ƙunshi lysine (Lys), proline (Pro), da valine (Val). Wani guntu mai aiki ne na α-melanocyte-stimulating hormone (α-MSH) tare da ayyukan ilimin halitta daban-daban. KPV yana aiwatar da tasirin sa ta hanyar aikin anti-mai kumburi da haɓakar gyaran nama. Yana daidaita matakan cytokine mai kumburi, yana hana sakin matsakanci mai kumburi, kuma yana rage martanin kumburin gida. A lokaci guda, yana haɓaka ƙaurawar tantanin halitta da haɓakawa, haɓaka gyare-gyare da haɓakar mucosa mai lalacewa ko kyallen takarda don ƙirƙirar yanayi mai kyau don warkar da rauni. Babban darajar warkewarta ta ta'allaka ne a cikin magance cututtukan kumburi. Don ulcerative colitis, KPV ana gudanar da rectally ko baki (sau da yawa ana inganta shi tare da nanocarriers ko hydrogels don ingantacciyar manufa) yana rage yawan kumburi na hanji, yana gyara lalacewar mucosal, yana rage alamun ayyukan cututtuka, kuma yana inganta farfadowar ilimin halittar jiki. A cikin dermatology, KPV's anti-mai kumburi Properties ana bincikowa da kuma melanocyte-haɓaka tasirin maganin vitiligo. Tsarin bayarwa na Topical yana haɓaka haɓakar melanin da haɓakar tantanin halitta, yana taimakawa sake dawo da fata da ta shafa. Bugu da ƙari, kayan gyaran nama nasa suna ba da damar warkewa don wasu raunin mucosal ko yanayin da ke da alaƙa da kumburi.

Menene BPC-157?

BPC-157 yana aiwatar da ayyukan ilimin halitta da yawa ta hanyar daidaita maganganun maɓalli masu mahimmanci irin su ƙwararrun ƙwayoyin cuta na jijiyoyi, endothelial nitric oxide synthase, da masu karɓa na hormone girma, yana nuna tasiri na musamman a gyaran nama da kariya. Yana haɓaka ƙaura na fibroblast da haɓakar collagen, yana haɓaka angiogenesis, kuma yana ba da kyallen kyallen takarda tare da isasshen tallafin abinci mai gina jiki da gyare-gyare, cimma tasirin kariyar tsarin salula.

A cikin aikace-aikacen gastrointestinal, ƙimar sa yana da mahimmanci: yana gyara lalacewar mucosal na ciki yadda ya kamata, yana magance ulcers da barasa ko NSAIDs suka jawo, yana rage yankin miki, kuma yana inganta warkarwa. Don cututtukan hanji mai kumburi kamar ulcerative colitis da cutar Crohn, yana rage sakin furotin mai kumburi, yana rage kumburin hanji, yana hanzarta gyarawa a wuraren anastomotic, kuma yana haɓaka aikin hanji.

A cikin tsarin musculoskeletal, BPC-157 yana kunna hanyoyin da ke da alaƙa da haɓakar ƙwayoyin tsoka da ƙaura, inganta gyaran gyare-gyare bayan raunin jijiya da ligament da rage lokacin dawowa bayan raunin wasanni ko tiyata. Hakanan yana hanzarta warkar da lahani na kashi da farfadowar guringuntsi, yana rage kumburin haɗin gwiwa, kuma yana tasiri ga yanayin kamar osteoarthritis.

Game da neuroprotection, yana canza yanayin maganganun hippocampal a cikin nau'ikan raunin kashin baya don taimakawa aikin dawo da motar. Yana rage lalacewar neuronal da ke haifar da ischemia na cerebral, yana rage raunin jijiya bayan bugun jini, kuma yana rage alamun alamun cutar Parkinson da schizophrenia, yana nuna yuwuwar neuroprotective. BPC-157 yana inganta warkarwa a cikin ƙonawa, rauni, da raunuka bayan aiki. Ta hanyar inganta kwararar jini zuwa kyallen takarda na ischemic, yana ba da fa'idodin warkewa ga cututtukan ischemic.

Kammalawa

Haɗin gwiwar haɗin gwiwa na TB500, KPV, da BPC-157 a cikin gauran Coremend yana kafa cibiyar sadarwa ta kayyade na 'anti-mai kumburi - gyare-gyare - sabuntawa' cibiyar sadarwa na ka'ida, samun cikakkiyar tasirin ilimin halitta wanda ba za a iya samu ta kowane bangare ba. KPV yana ba da fifikon rage ƙumburi na nama na gida ta hanyar hana ƙwayar ƙwayar cuta ta pro-inflammatory, haifar da ƙananan ƙananan ƙananan ƙwayoyin cuta wanda ya dace don gyara na gaba. Ƙaddamar da haɓakar ƙwayoyin mucosal da ƙaura yana fara aikin gyaran gyare-gyare a yankunan da suka lalace. Gina kan wannan harsashi, TB500 yana haɓaka ƙaura ta tantanin halitta ta hanyar daidaita haɓakar actin yayin da lokaci guda yana haɓaka haɓakar angiogenesis da haɓakar collagen, yana ba da tushen kayan aikin gyaran nama. Farkon sa na farfadowar nama mai haɗi yana samar da tsarin aiki tare tare da KPV's farkon matakin kumburi. BPC-157 yana haɓaka haɓakar angiogenesis ta hanyar haɓaka maganganun kwayoyin halitta na haɓakar haɓakar haɓakar ƙwayoyin cuta da endothelial nitric oxide synthase, yayin haɓaka ayyukan fibroblast. Wannan yana haɓaka tasirin angiogenic na TB500 don tabbatar da samar da abinci mai gina jiki kuma yana rage lalacewa na biyu yayin gyara ta hanyar aikin cytoprotective. Ƙarfin gyare-gyaren nama mai yawa (magungunan gastrointestinal, tsarin musculoskeletal, tsarin juyayi) ya dace da farfadowar nama na TB500 da gyaran mucosal na KPV ta hanyar haɗin kai da aka yi niyya. Lokacin da aka haɗa kai, KPV's anti-inflammatory mataki yana kawar da shingen gyarawa, farfadowa na TB500 ya kafa ginshiƙan tsari, da haɓaka aikin BPC-157 da kariyar tantanin halitta yana haɓaka inganci da inganci. Tare, suna haɓaka tsarin gaba ɗaya daga ƙudurin kumburi zuwa gyare-gyaren tsari da dawo da aiki a cikin kyallen takarda da suka lalace, suna ba da samfurin tsaka-tsakin tsaka-tsakin tsaka-tsaki sosai don raunin nama mai rikitarwa da cututtukan da ke da alaƙa da kumburi.

Game da Marubuci

Abubuwan da aka ambata a sama duk bincike ne, gyara su kuma Cocer Peptides ne suka haɗa su.

DUKKANIN LABARI DA BAYANIN KYAUTATAWA DA AKE BAYAR A WANNAN SHAFIN KAWAI DOMIN WATSA BAYANI NE DA MANUFOFIN ILIMI.  

Kayayyakin da aka bayar akan wannan gidan yanar gizon an yi niyya ne kawai don binciken in vitro. Binciken in vitro (Latin: *a cikin gilashi*, ma'ana a cikin gilashin gilashi) ana gudanar da shi a wajen jikin mutum. Waɗannan samfuran ba magunguna ba ne, Hukumar Abinci da Magunguna ta Amurka (FDA) ba ta amince da su ba, kuma dole ne a yi amfani da su don hanawa, magani, ko warkar da kowane yanayi na likita, cuta, ko cuta. Doka ta haramta shigar da waɗannan samfuran cikin jikin mutum ko dabba ta kowace hanya.